​

Funding Round

Series A - Bioniz Therapeutics

Series A - Bioniz Therapeutics

Investment Firm

Overview

Bioniz is a biotechnology company focuses on discovering small peptides and molecules for the treatment of autoimmune diseases and cancer.

Announced Date

Aug 01, 2016

Closed on Date

Jan 01, 2016

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

David Pyott

David Pyott

David Pyott is a seed firm.

Takeda Ventures

Takeda Ventures

Takeda Ventures is a early_stage_venture and late_stage_venture firm.

Participant Investors

4

Investor Name
Participant InvestorTakeda Ventures
Participant InvestorDavid Pyott
Participant InvestorSignatures Capital
Participant InvestorCota Capital

Round Details and Background

Bioniz Therapeutics raised $13000000 on 2016-08-01 in Series A

Bioniz is a biotechnology company focuses on discovering small peptides and molecules for the treatment of autoimmune diseases and cancer.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 15, 2014
Seed Round - Bioniz Therapeutics
-717.6K
Aug 01, 2016
Series A - Bioniz Therapeutics
4-13.0M
Aug 15, 2013
Seed Round - Bioniz Therapeutics
1-599.2K

Recent Activity

There is no recent news or activity for this profile.